Skip to main content
syn
Daily Digest

Matthew Perry's assistant jailed over ketamine death

Published Wednesday, May 27, 2026 · Updated May 28

Share on X

Source Balance

Center-Dominant
Left 25%Center 75%Right 0%

Media Analysis

AI synthesis

Matthew Perry's former assistant, Kenneth Iwamasa, has been sentenced to 41 months in prison in Los Angeles for his role in the actor's death from a ketamine overdose. Iwamasa pleaded guilty to conspiracy to distribute ketamine causing death and admitted to injecting Perry with the drug at his request. This sentencing concludes the prosecution of five individuals involved in the case.

What We Know — Key Points

  • Kenneth Iwamasa, Matthew Perry's live-in assistant, was sentenced to 41 months in prison on Wednesday in a Los Angeles courtroom for his role in providing ketamine that led to the actor's death.
  • Iwamasa pleaded guilty to conspiracy to distribute ketamine causing death.
  • Iwamasa admitted to injecting Perry with the drug at his request.
  • His sentencing concludes the prosecution of five individuals involved in the case.

What Is Claimed — Perspectives

  • BBC NewsCenter

    BBC News reports that Matthew Perry's live-in assistant, Kenneth Iwamasa, was sentenced to 41 months in prison for his role in providing ketamine that led to the actor's death. Iwamasa pleaded guilty to conspiracy to distribute ketamine causing death and was the last of five defendants to be sentenced.

  • Al Jazeera EnglishCenter-Left

    Al Jazeera English states that Kenneth Iwamasa, Matthew Perry's former personal assistant, received a 41-month prison sentence for his involvement in the actor's death from a ketamine overdose. The article notes Iwamasa admitted to injecting Perry with the drug at his request, and his sentencing marks the conclusion of the prosecution for five individuals in the case.

AI-Generated Content

  • This topic was generated by an AI system.
  • Key points, perspectives, bias labels, and categorisation may contain errors.
  • This is not journalism. Do not rely on this content for critical decisions.
  • Read our full AI disclaimer for details.